Bank of America
GCTK icon

Bank of America’s GlucoTrack GCTK Stock Holding History

Bank of America’s Portfolio GCTK Stock Details GCTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28
Closed -$108 – 6170
2025
Q4 		$108 Buy
28
+21
+300% +$125 ﹤0.01% 6806
2025
Q3 		$46 Sell
7
-4,082
-100% -$24.6K ﹤0.01% 8029
2025
Q2 		$24.5K Buy
+4,089
New +$35.9K ﹤0.01% 7009
2025
Q1 		– Hold
0
– – – 8275
2024
Q4 		– Hold
0
– – – 8078
2024
Q3 		– Hold
0
– – – 7765

Other funds holding GCTK

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
AF
Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Bank of America's GCTK Position: Q1 2026 in Review

Bank of America sold out of GlucoTrack (GCTK) in Q1 2026, closing a stake of 28 shares — an estimated $108 sold.

Bank of America first reported a position in GCTK in Q2 2025 and held it in 3 quarters. The position peaked at $24.5K in Q2 2025. 13 funds tracked by Wall St. Rank hold GCTK as of Q1 2026.

  • Bank of America reported no remaining GlucoTrack position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 28 GlucoTrack shares in Q1 2026, an estimated $108.
  • Bank of America first reported a position in GlucoTrack in Q2 2025 and held it in 3 quarters.
  • Bank of America's GlucoTrack position peaked at $24.5K in Q2 2025.
  • 13 funds tracked by Wall St. Rank held GlucoTrack as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.